Page last updated: 2024-12-07

methyldeoxyspergualin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

15-deoxymethylspergualin: act on the proliferation & differentiation of T cells which respond to growth factors, such as IL-2 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID126996
CHEMBL ID1771562
SCHEMBL ID9772181
MeSH IDM0206705

Synonyms (19)

Synonym
15-deoxy-11-o-methylspergualin
114760-35-9
heptanamide, 7-((aminoiminomethyl)amino)-n-(2-((4-((3-amino propyl)amino)butyl)amino)-1-methoxy-2-oxoethyl)-, (s)-
(-)-15-deoxy-11-o-methylspergualin
medsg
deoxymethylspergualin
methyldeoxyspergualin
15-medsg
15-deoxymethylspergualin
heptanamide, 7-((aminoiminomethyl)amino)-n-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-methoxy-2-oxoethyl)-
deoxymethyspergualin
1-amino-19-guanidino-11-methoxy-4,9,12-triazanonadecane-10,13-dione
98629-44-8
CHEMBL1771562
n-[4-(3-aminopropyl)aminobutyl]-2-(7-guanidinoheptanamido)-2-methoxyethanamide
HFNDGMJKLKYYRZ-UHFFFAOYSA-N
SCHEMBL9772181
DTXSID90913155
n-[2-({4-[(3-aminopropyl)amino]butyl}imino)-2-hydroxy-1-methoxyethyl]-7-carbamimidamidoheptanimidic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID595073Chemical stability of the compound in aqueous buffer assessed as half life at pH 7 by thin layer chromatography2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Improved synthesis of 15-deoxyspergualin analogs using the Ugi multi-component reaction.
AID595046Chemical stability of the compound in aqueous buffer assessed as half life at pH 8 by thin layer chromatography2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Improved synthesis of 15-deoxyspergualin analogs using the Ugi multi-component reaction.
AID595048Antibacterial activity against Escherichia coli2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Improved synthesis of 15-deoxyspergualin analogs using the Ugi multi-component reaction.
AID595049Antibacterial activity against Bacillus subtilis2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Improved synthesis of 15-deoxyspergualin analogs using the Ugi multi-component reaction.
AID595047Chemical stability of the compound in aqueous buffer assessed as half life at pH 10 by thin layer chromatography2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Improved synthesis of 15-deoxyspergualin analogs using the Ugi multi-component reaction.
AID595072Chemical stability of the compound in aqueous buffer assessed as half life at pH 5 by thin layer chromatography2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Improved synthesis of 15-deoxyspergualin analogs using the Ugi multi-component reaction.
AID595050Antibacterial activity against Staphylococcus aureus2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Improved synthesis of 15-deoxyspergualin analogs using the Ugi multi-component reaction.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (17.24)18.7374
1990's19 (65.52)18.2507
2000's3 (10.34)29.6817
2010's2 (6.90)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.41 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]